(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
@ $36.11
Issued: 14 Feb 2024 @ 13:49
Return: 10.57%
Previous signal: Feb 13 - 12:40
Previous signal:
Return: 0.46 %
Live Chart Being Loaded With Signals
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases...
Stats | |
---|---|
Today's Volume | 480 273 |
Average Volume | 930 214 |
Market Cap | 2.63B |
EPS | $0 ( 2024-05-02 ) |
Next earnings date | ( $-0.690 ) 2024-06-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.96 |
ATR14 | $0.0820 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Jimenez Freddy A. | Buy | 20 000 | Common Stock |
2024-02-13 | Jimenez Freddy A. | Buy | 4 166 | Common Stock |
2024-02-13 | Jimenez Freddy A. | Sell | 4 166 | Incentive Stock Option (Right to Buy) |
2024-02-13 | Jimenez Freddy A. | Sell | 20 000 | Incentive Stock Option (Right to Buy) |
2024-01-02 | Martin Samuel Bates | Buy | 10 750 | Common Stock |
INSIDER POWER |
---|
75.42 |
Last 97 transactions |
Buy: 2 900 849 | Sell: 507 801 |
Volume Correlation
Celldex Therapeutics Inc Correlation
10 Most Positive Correlations | |
---|---|
NSTS | 0.918 |
BOKF | 0.917 |
FNWD | 0.917 |
GCBC | 0.916 |
NECB | 0.913 |
UMBF | 0.913 |
MSBI | 0.91 |
HMNF | 0.909 |
AHPI | 0.907 |
FSBC | 0.906 |
10 Most Negative Correlations | |
---|---|
CHMA | -0.906 |
VTIP | -0.906 |
DSPG | -0.895 |
SUMO | -0.893 |
SOPH | -0.887 |
SMED | -0.882 |
OSMT | -0.878 |
NVCN | -0.876 |
MNTV | -0.876 |
DVCR | -0.872 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Celldex Therapeutics Inc Correlation - Currency/Commodity
Celldex Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $6.88M |
Gross Profit: | $3.88M (56.30 %) |
EPS: | $-2.92 |
FY | 2023 |
Revenue: | $6.88M |
Gross Profit: | $3.88M (56.30 %) |
EPS: | $-2.92 |
FY | 2022 |
Revenue: | $2.36M |
Gross Profit: | $957 000 (40.60 %) |
EPS: | $-2.62 |
FY | 2021 |
Revenue: | $4.65M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.640 |
Financial Reports:
No articles found.
Celldex Therapeutics Inc
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators